The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> BIOLOGY >> NEWS
Study contradicts USA warning that an antidepressant can cause congenital abnormalities

Prague, Czech Republic: A study carried out by German researchers has failed to show that a popular antidepressant, paroxetine, causes congenital abnormalities if taken by pregnant women, the 22nd annual conference of the European Society of Human Reproduction and Embryology heard today (Monday).

Dr Wolfgang Paulus said the results were important because they contradicted a warning issued by the US Food and Drug Administration in October 2005 that the use of paroxetine (brand names: Seroxat, Paxil, Aropax, Deroxat or Pondera) could increase the risk of major congenital abnormalities. The warning may have caused women to terminate their pregnancies unnecessarily.

Dr Paulus, director of the Institute of Reproductive Toxicology at the University of Ulm, Germany, told a news briefing: "Our results show the importance of a reliable pharmaco-vigilance system documenting foetal outcome after medication in pregnancy. We need international networks of registries to do this, but financial support for this purpose is lacking. We hope for more serious efforts from the pharmaceutical industry and governmental authorities in Europe. We think that this is also an ethical challenge because many patients opt for termination of pregnancy due to fear of congenital malformations.

The FDA warning about the drug, which is a selective serotonin reuptake inhibitor (SSRI), was issued on the basis of unpublished research. "It showed that the absolute rate of major congenital malformations seen in the first trimester for paroxetine users was 4%, and 2% for cardiovascular malformations. Yet the retrospective study of 5,956 women by the producer, GlaxoSmithKline, had only 591 cases of medication with paroxetine during the first trimester and did not include controls of women not taking an antidepressant," he said.*

In contrast, the research carried out by Dr Paulus and his colleagues was a prospective follow-up study that collected data on pregnancy outcomes aft
'"/>

Contact: Emma Mason
wordmason@mac.com
44-771-129-6986
European Society for Human Reproduction and Embryology
19-Jun-2006


Page: 1 2 3

Related biology news :

1. Study begins to reveal clues to the cause and progression of sepsis
2. Study finds gender differences in renal and other genes contributing to blood pressure
3. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
4. Study: Sticking to the sand might not be such good, clean fun for beachgoers
5. Study points to new way to predict death risk from torn aorta
6. Study identifies new gene therapy tools for inherited blindness
7. Study finds contaminated water reaching Floridas offshore keys
8. Study sheds light on why humans walk on two legs
9. Study explains how pathogens evolve to escape detection
10. Study finds hereditary link to premenstrual depression
11. Study identifies energy efficiency as reason for evolution of upright walking

Post Your Comments:
(Date:11/23/2009)...ciated strain of the deadly superbug MRSAan infect...bioticsposes a far greater health threat than prev... according to a study in the December issue of Em...s easily picked up in fitness centers, schools, an...l burden of MRSA within hospitals, the report foun...
(Date:11/23/2009)...gests that a common oral bacterium may exacerbate ... et al, "Unique Lipids from a Common Human Bacteri...f Enhancing Autoimmunity," appears in the December.... , Multiple sclerosis (MS), a disease where the...affects nearly 1 in 700 people in the United State...
(Date:11/23/2009)... University of Alabama at Birmingham (UAB) researc...ing medical conditions (co-morbidity) do not expla...mericans compared to Caucasians who also have colo... Cancer , a journal of the American Cancer Societ... co-morbidity are independent predictors of poor s...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2VIASPACE Pursuing Renewable Energy Business in Asia 13353 1VIASPACE Pursuing Renewable Energy Business in Asia 13353 2VIASPACE Pursuing Renewable Energy Business in Asia 13353 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 1Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 2Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 4Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 5Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 6Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 1Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 2Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 3Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 4Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 5Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 6Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 7Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 8Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 9Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 10Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 11Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 12Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 13Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 14Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 15Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 16Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 17Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 18Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 19Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 20Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 21Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 22Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 23
(Date:11/24/2009)...dBLENHEIM,Ontario,Nov.24/PRNewswire-FirstCall/--Do...ssetsofHylandSeeds,adivisionofThompsonsLimitedofBl...expandDowAgroSciences,currentseedsbusinessasthecom... 2010 andDowAgroSciencesHerbicideTolerantTraitTec...dinthenearfuture. ,, "Thisacquisitionbringstoge...
(Date:11/24/2009)...Nov.24/PRNewswire-Asia/--NODPharmaceuticalsInc.ann...wedthepatentapplicationfor,itsnano-particleoraldel...yefficientapproachtoincorporatepeptidesor,proteins...ofdrugs,otherwiseadministeredasinjections.NODtechn...acromoleculardrugssuchasinsulin,interferon,growth...
(Date:11/24/2009)...ficacyendpointhasbeenmetforpatientswithadvanced-st...Y,Nov.24/PRNewswire-FirstCall/-AEternaZentarisInc....armaceuticalcompanyfocusedonendocrinetherapyandonc...2studywithitstargetedcytotoxicpeptideconjugate,AEZ...rrentendometrialcancer.Inapersonalizedhealthcareap...
(Date:11/24/2009)...ly,November24/PRNewswire/--HealthRoboticstodayanno...groupofselected,investors.ThisrecentlyformedToront...csCanada,Inc.andwillmarket,install,andsupport,Heal...sthe,revolutionaryproductofferingsi.v.STATION(TM),...illalsoprovideassistanceonan"asneeded,basis"toitss...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
Other News:
CURTAILING THE HIV EPIDEMIC WITH EXPANDED TESTING FOR PRIMARY HIV INFECTION OF PATIENTS WITH ACUTE VIRAL ILLNESS SYMPTOMS ...Expanded testing for primary HIV infection among patients with fever or oth
...The American Society for Clinical Pathology (ASCP)...tely $1.5 million in federal funds to continue to ...t programs in African countries severely affected ...boratory professionals in Africa and will continue...
...icians have discovered how certain insects can cli...water's surface without moving their limbs -- and ...the tiny creatures that live on the surface of pon...e, "all the rules change," said David Hu, a gradua...
...y oceanographers have developed an explanation for...ve a large variability in nutrient supplies needed...t the food web of marine life. ......The circulati...ubtropical gyre," swirls in a clockwise direction ...
Sept/Oct 2005 Annals of Family Medicine tip sheet 2Sept/Oct 2005 Annals of Family Medicine tip sheet 3Sept/Oct 2005 Annals of Family Medicine tip sheet 4Sept/Oct 2005 Annals of Family Medicine tip sheet 5Sept/Oct 2005 Annals of Family Medicine tip sheet 6Laboratory professionals in Africa receive training under AIDS Relief Plan 2It's a bug's life: MIT team tells moving tale 2Duke scientists explain gaps in nutrient availability within North Atlantic 2Duke scientists explain gaps in nutrient availability within North Atlantic 3
...xperts who last year traced the source of a bacter...onchoscopes say more rigorous regulation and faste...break.... ..."The regulation of devices used for m...ulation of drugs prescribed by doctors," said Arju...
...l Institutes of Health have discovered how an embr...t appears to be one of the earliest steps needed t..., the researchers found that 6 days after an egg i...s on its surface and molecules on the surface of t...
MADISON, WI, JANUARY 16, 2003 A pesticide used extensively all over the world is receiving attention these days more for methods being used to clean it up than for its use as chemical to control inse
...nd colleagues from the University of California ar...t can reversibly switch properties in response to ...ystems that could, for example, release or absorb ... In the Jan. 17 issue of Science, the researchers...
Medical devices safe, but could be safer with better regulation 2Researchers discover how embryo attaches to the uterus 2Researchers discover how embryo attaches to the uterus 3Researchers discover how embryo attaches to the uterus 4Scientists target microorganisms to break down toxic pesticide 2MITs smart surface switches properties reversibly 2MITs smart surface switches properties reversibly 3